Mobile Phone-Based Microscopes Diagnose Intestinal Parasites
|
By LabMedica International staff writers Posted on 13 Jul 2016 |

Image: Handheld- and mobile phone-based microscopes: A) The Newton Nm1-600 XY portable field microscope B) The reversed-lens CellScope attached to an iPhone 5s (Photo courtesy of University Health Network).
Handheld, mobile phone-based microscopes can be used in developing countries after minimal training of community laboratory technicians to diagnose intestinal parasites quickly and accurately.
Intestinal worms affect almost two billion people world-wide, predominantly in areas with poor sanitation and unsafe water and in children, these parasites may lead to malnutrition, stunted growth and development and can lead to chronic disability, with serious health and economic consequences.
An international team of scientists led by those at the University of Toronto (ON, Canada) trained local laboratory technicians to operate the two handheld microscopes. In total, the technicians examined stool and urine samples from 226 individuals for the detection of parasites. The accuracy of all slides was evaluated by all microscopes: the two handheld devices, as well as a conventional, “gold standard” microscope.
The two portable handheld microscopes:tested were a commercial Newton Nm1 microscope (Newton Microscopes, Bedford, UK) and a mobile phone-based CellScope (CellScope Inc, San Francisco, CA, USA) which is essentially a smartphone with a special custom-fitted lens attached over the camera and light source, developed by engineers, to detect intestinal parasites. Slides were first evaluated using an Olympus CX21 microscope (Volketswil, Switzerland) as the gold standard.
The scientists reported that the two handheld microscopes were very good at ruling in infections, and the Newton portable microscope was able to detect even very low-burden infections. The CellScope missed some low-burden infections, however newer iterations of this device are currently being tested to increase its sensitivity.
Isaac I. Bogoch, MD, the lead investigator said, “It was heart-warming to see how well and easily these portable, handheld field microscopes were adopted and used in a rural setting. This will help us map out the areas of greatest need. Novel diagnostic approaches for common parasitic infections could have a profound impact on care of patients, as well as on public health approaches to screening in resource-poor areas.” The study was published on June 27, 2016, in the journal PLOS Neglected Tropical Diseases.
Related Links:
University of Toronto
Newton Microscopes
CellScope
Olympus
Intestinal worms affect almost two billion people world-wide, predominantly in areas with poor sanitation and unsafe water and in children, these parasites may lead to malnutrition, stunted growth and development and can lead to chronic disability, with serious health and economic consequences.
An international team of scientists led by those at the University of Toronto (ON, Canada) trained local laboratory technicians to operate the two handheld microscopes. In total, the technicians examined stool and urine samples from 226 individuals for the detection of parasites. The accuracy of all slides was evaluated by all microscopes: the two handheld devices, as well as a conventional, “gold standard” microscope.
The two portable handheld microscopes:tested were a commercial Newton Nm1 microscope (Newton Microscopes, Bedford, UK) and a mobile phone-based CellScope (CellScope Inc, San Francisco, CA, USA) which is essentially a smartphone with a special custom-fitted lens attached over the camera and light source, developed by engineers, to detect intestinal parasites. Slides were first evaluated using an Olympus CX21 microscope (Volketswil, Switzerland) as the gold standard.
The scientists reported that the two handheld microscopes were very good at ruling in infections, and the Newton portable microscope was able to detect even very low-burden infections. The CellScope missed some low-burden infections, however newer iterations of this device are currently being tested to increase its sensitivity.
Isaac I. Bogoch, MD, the lead investigator said, “It was heart-warming to see how well and easily these portable, handheld field microscopes were adopted and used in a rural setting. This will help us map out the areas of greatest need. Novel diagnostic approaches for common parasitic infections could have a profound impact on care of patients, as well as on public health approaches to screening in resource-poor areas.” The study was published on June 27, 2016, in the journal PLOS Neglected Tropical Diseases.
Related Links:
University of Toronto
Newton Microscopes
CellScope
Olympus
Latest Technology News
- New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
- Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
- Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
- Online Tool Supports Family Screening for Inherited Cancer Risk
- Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
- New Electronic Pipette Enhances Workflows with Touchscreen Control
- AI Model Outperforms Clinicians in Rare Disease Detection
- AI-Driven Diagnostic Demonstrates High Accuracy in Detecting Periprosthetic Joint Infection
- Blood Test “Clocks” Predict Start of Alzheimer’s Symptoms
- AI-Powered Biomarker Predicts Liver Cancer Risk
- Robotic Technology Unveiled for Automated Diagnostic Blood Draws
- ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Channels
Clinical Chemistry
view channel
New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs
Steroid hormone measurement is a core application of clinical mass spectrometry, which is widely regarded as a diagnostic gold standard. Access to these high-specificity methods has often been constrained... Read more
Study Shows Dual Biomarkers Improve Accuracy of Alzheimer’s Detection
Alzheimer’s disease develops slowly, and biological changes can appear in blood many years before symptoms. While plasma assays for phosphorylated tau offer earlier detection, discerning whether these... Read moreMolecular Diagnostics
view channel
New Molecular Test Boosts Accuracy of Bile Duct Cancer Diagnosis
Bile duct strictures can arise from cancer or benign disease, but their location within ducts connecting the liver, gallbladder, and intestines complicates evaluation. Standard biopsy and cytology may... Read moreAdaptive PCR Platform Improves Consistency in Small-Batch NGS Workflows
PCR amplification during next-generation sequencing (NGS) library preparation can introduce variability, often requiring manual quantification and risking over-cycling artifacts. The issue is especially... Read more
First IVDR‑Certified IGH Clonality Assay Supports Diagnosis of B-Cell Malignancies
Accurate identification of clonal immunoglobulin heavy chain (IGH) gene rearrangements is central to evaluating suspected B-cell lymphoproliferative disorders, where a single B-cell clone yields a defining... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas
Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read morePathology
view channel
AI-Based Pathology Model Guides Chemotherapy Decisions in Breast Cancer
Selecting adjuvant chemotherapy for early-stage breast cancer remains a difficult decision because only a subset benefits and many undergo toxicity without gain. Genomic assays can help but are costly,... Read more
Biopsy-Based Gene Test Predicts Recurrence Risk in Lung Adenocarcinoma
Lung cancer is the leading cause of cancer death, killing more people in the United States than breast, prostate, and colon cancers combined. In lung adenocarcinoma (LUAD), tumors that invade nearby blood... Read moreTechnology
view channel
New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
Children with T-cell acute lymphoblastic leukemia face an aggressive disease that remains difficult to treat. Although remission rates have improved, many survivors experience long-term effects from intensive... Read more
Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
Mass spectrometry is central to identifying and quantifying molecules in complex biological samples, but conventional instruments typically analyze ions sequentially, which can limit detection of rare species.... Read moreIndustry
view channel
Lunit and CellCarta Collaborate to Expand AI Pathology in CDx Development
Lunit (Seoul, South Korea), a leading provider of AI for cancer diagnostics and precision oncology, and CellCarta (Montreal, QC, Canada), a global contract research organization (CRO) laboratory serving... Read more








